Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of SHC014748M capsules in relapsed or refractory peripheral T-cell lymphoma
CTR20201332Phase 2Active
- Sponsor
- Shenghe Pharmaceutical
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of shc014748m in peripheral T-cell lymphoma (PTCL), sponsored by Shenghe Pharmaceutical. Started Sep 2020; status: active.
02
Drugs
shc014748m
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on CTR20201332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20201332.